Cargando…
非小细胞肺癌吉西他滨药物耐药相关基因研究进展
With the development of pharmacogenomics and pharmacogenetics, personal therapy based on genes has become one of the most effective ways to enhance chemotherapeutic effect on non-small cell lung cancer (NSCLC) patients. Much attention has been paid to validate the predictive biomarkers of chemothera...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000321/ https://www.ncbi.nlm.nih.gov/pubmed/21569648 http://dx.doi.org/10.3779/j.issn.1009-3419.2011.05.08 |